Literature DB >> 3199067

Resistance of cytolytic lymphocytes to perforin-mediated killing. Lack of correlation with complement-associated homologous species restriction.

S B Jiang1, P M Persechini, A Zychlinsky, C C Liu, B Perussia, J D Young.   

Abstract

CTL and NK cells resist self-mediated killing and lysis by their own pore-forming protein (PFP; perforin). Perforin, like C, lyses RBC. Efficient C-mediated lysis of RBC occurs when both C and RBC are from different species (homologous species restriction). A protective surface protein (C8-binding protein, homologous restriction factor) has been reported to mediate both homologous species restriction in C-dependent cytolysis and protection of some target cells against perforin-induced lysis. We show here that perforin, unlike C, lyses target cells across a variety of species, including the homologous one, while the same target cell populations resist the attack by homologous C. Perforin-containing extracts of CTL and LAK/NK cells from three species (rat, mouse, and human) and purified mouse perforin were tested against RBC from 10 different species, several nucleated target cell lines, and one primary cell population (thymocytes). While resisting lysis by homologous C, most of these cell types were lysed effectively by perforin without any homologous restriction pattern. CTL and NK cells, like other nucleated targets, are resistant to lysis by homologous but not heterologous C; however, these cell types are resistant to both homologous and heterologous perforin. Together, our results suggest that the protective mechanisms associated with C- and perforin-mediated lysis are distinct.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3199067      PMCID: PMC2189133          DOI: 10.1084/jem.168.6.2207

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  39 in total

1.  Lytic activity of C5-9 complexes for erythrocytes from the species other than sheep: C9 rather than C8-dependent variation in lytic activity.

Authors:  K I Yamamoto
Journal:  J Immunol       Date:  1977-10       Impact factor: 5.422

Review 2.  The molecular basis of target cell killing by human lymphocytes and of killer cell self-protection.

Authors:  H J Müller-Eberhard
Journal:  Immunol Rev       Date:  1988-03       Impact factor: 12.988

3.  Immunoglobulin and theta-bearing murine leukemias and lymphomas.

Authors:  E M Shevach; J D Stobo; I Green
Journal:  J Immunol       Date:  1972-05       Impact factor: 5.422

Review 4.  Human natural killer cells: biologic and pathologic aspects.

Authors:  G Trinchieri; B Perussia
Journal:  Lab Invest       Date:  1984-05       Impact factor: 5.662

Review 5.  Cytotoxic T-lymphocytes. How do they function?

Authors:  G Berke
Journal:  Immunol Rev       Date:  1983       Impact factor: 12.988

6.  Species-restricted target cell lysis by human complement: complement-lysed erythrocytes from heterologous and homologous species differ in their ratio of bound to inserted C9.

Authors:  V W Hu; M L Shin
Journal:  J Immunol       Date:  1984-10       Impact factor: 5.422

Review 7.  Heterogeneity of natural killer cells.

Authors:  J R Ortaldo; R B Herberman
Journal:  Annu Rev Immunol       Date:  1984       Impact factor: 28.527

8.  Homologous species restriction in lysis of erythrocytes by terminal complement proteins.

Authors:  G M Hänsch; C H Hammer; P Vanguri; M L Shin
Journal:  Proc Natl Acad Sci U S A       Date:  1981-08       Impact factor: 11.205

9.  Evidence for restriction of the ability of complement to lyse homologous erythrocytes.

Authors:  J J Houle; E M Hoffmann
Journal:  J Immunol       Date:  1984-09       Impact factor: 5.422

10.  Human natural killer cells analyzed by B73.1, a monoclonal antibody blocking Fc receptor functions. I. Characterization of the lymphocyte subset reactive with B73.1.

Authors:  B Perussia; S Starr; S Abraham; V Fanning; G Trinchieri
Journal:  J Immunol       Date:  1983-05       Impact factor: 5.422

View more
  14 in total

1.  Killing of cells by perforin. Resistance to killing is not due to diminished binding of perforin to the cell membrane.

Authors:  J Jones; B P Morgan
Journal:  Biochem J       Date:  1991-11-15       Impact factor: 3.857

Review 2.  Membrane defence against complement lysis: the structure and biological properties of CD59.

Authors:  A Davies; P J Lachmann
Journal:  Immunol Res       Date:  1993       Impact factor: 2.829

3.  Comparative susceptibility of peripheral blood leucocytes and related cell lines to killing by T-cell perforin.

Authors:  J Jones; B P Morgan
Journal:  Immunology       Date:  1994-08       Impact factor: 7.397

Review 4.  Resistance to anticancer immunity in cancer patients: potential strategies to reverse resistance.

Authors:  B Bonavida; S Chouaib
Journal:  Ann Oncol       Date:  2017-03-01       Impact factor: 32.976

5.  Molecular cloning and chromosomal assignment of a human perforin (PFP) gene.

Authors:  Y Shinkai; M C Yoshida; K Maeda; T Kobata; K Maruyama; J Yodoi; H Yagita; K Okumura
Journal:  Immunogenetics       Date:  1989       Impact factor: 2.846

6.  Resistance of cytolytic lymphocytes to perforin-mediated killing. Induction of resistance correlates with increase in cytotoxicity.

Authors:  C C Liu; S Jiang; P M Persechini; A Zychlinsky; Y Kaufmann; J D Young
Journal:  J Exp Med       Date:  1989-06-01       Impact factor: 14.307

7.  Human protectin (CD59), an 18-20-kD homologous complement restriction factor, does not restrict perforin-mediated lysis.

Authors:  S Meri; B P Morgan; M Wing; J Jones; A Davies; E Podack; P J Lachmann
Journal:  J Exp Med       Date:  1990-07-01       Impact factor: 14.307

8.  Inactivation of human immunodeficiency virus (HIV)-1 envelope-specific CD8+ cytotoxic T lymphocytes by free antigenic peptide: a self-veto mechanism?

Authors:  H Takahashi; Y Nakagawa; G R Leggatt; Y Ishida; T Saito; K Yokomuro; J A Berzofsky
Journal:  J Exp Med       Date:  1996-03-01       Impact factor: 14.307

9.  Purified perforin induces target cell lysis but not DNA fragmentation.

Authors:  R C Duke; P M Persechini; S Chang; C C Liu; J J Cohen; J D Young
Journal:  J Exp Med       Date:  1989-10-01       Impact factor: 14.307

10.  Specific killing of cytotoxic T cells and antigen-presenting cells by CD4+ cytotoxic T cell clones. A novel potentially immunoregulatory T-T cell interaction in man.

Authors:  T H Ottenhoff; T Mutis
Journal:  J Exp Med       Date:  1990-06-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.